V

Variantyx

159 employees

Variantyx offers a comprehensive set of advanced genomic diagnostic products and services with a focus on whole genome sequencing.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Clinical reporting
Personal Health
Whole genome sequencing
Cancer predisposition
NGS data analysis
Rare diseases
Health Diagnostics
Health Care
Genetics
Genomic diagnostics
Life Science
Information Technology

Date founded

2014

Funding rounds raised

Total raised

$42M

from 12 investors over 12 rounds

V

Variantyx raised $20M on October 18, 2022

Investors: Kreos Capital

V

Variantyx raised $42M on February 14, 2022

Investors: 20/20 HealthCare Partners, Robert Bosch Venture Capital GmbH (RBVC), New Era Capital Partners, Peregrine Ventures and Pitango Venture Capital

V

Variantyx raised $6M on November 15, 2021

Investors: Robert Bosch Venture Capital GmbH (RBVC)

V

Variantyx raised $20M on March 15, 2021

Investors: 20/20 HealthCare Partners, Pitango Venture Capital and New Era Capital Partners

V

Variantyx raised $10M on June 5, 2019

Investors: New Era Capital Partners and Pitango Venture Capital

FAQ